Clinical Trial Update: Periprostatic Neurolysis in Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial at UT Southwestern is evaluating periprostatic neurolysis for prostate cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: PROSTATE CANCER, NERVES | Phase 1 | Status: RECRUITING